Skip to main content
Erschienen in: Diabetologia 10/2013

01.10.2013 | Article

Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study

Erschienen in: Diabetologia | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

This study evaluated whether repeated non-attendance for diabetic eye screening is associated with the risk of sight-threatening diabetic retinopathy (STDR).

Methods

This was a cohort study of 6,556 residents with diabetes who were invited for screening between 2008 and 2011 in a population-based eye screening programme in inner London and who attended for their first-ever screen in 2008. The proportion of participants with STDR was evaluated in relation to the number of years in which screening was missed.

Results

The proportion of participants who did not attend screening decreased between 2009 and 2011 (annual reduction 1.6% [95% CI 0.9%, 2.3%]). The adjusted relative odds of STDR for 210 participants who did not attend two consecutive years of screening were 3.76 (95% CI 2.14, 6.61; p < 0.001), compared with participants who were screened annually. In 605 participants with mild non-proliferative retinopathy at the first screen, the adjusted relative odds of developing proliferative or moderate to severe non-proliferative retinopathy were 5.72 (95% CI 7.43, 22.83; p = 0.013) for 53 participants who missed two screens.

Conclusions/interpretation

Patients who do not attend diabetic eye screening are at increased risk of developing STDR. Tracing of non-attenders with evidence of established retinopathy should be an important fail-safe procedure.
Literatur
1.
Zurück zum Zitat Resnikoff S, Pascolini D, Etya'ale D et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851PubMed Resnikoff S, Pascolini D, Etya'ale D et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851PubMed
2.
Zurück zum Zitat Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103:1796–1806CrossRef Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103:1796–1806CrossRef
3.
Zurück zum Zitat Diabetic Retinopathy Study Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic Retinopathy Study report no. 5. Dev Ophthalmol 2:248–261 Diabetic Retinopathy Study Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic Retinopathy Study report no. 5. Dev Ophthalmol 2:248–261
4.
Zurück zum Zitat English National Diabetic Eye Screening Programme (2011) Annual report 2010/2011. English National Diabetic Eye Screening Programme, Gloucester English National Diabetic Eye Screening Programme (2011) Annual report 2010/2011. English National Diabetic Eye Screening Programme, Gloucester
5.
Zurück zum Zitat James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 320:1627–1631PubMedCrossRef James M, Turner DA, Broadbent DM, Vora J, Harding SP (2000) Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 320:1627–1631PubMedCrossRef
6.
Zurück zum Zitat Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R (2012) Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr 6:199–202PubMedCrossRef Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R (2012) Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr 6:199–202PubMedCrossRef
7.
Zurück zum Zitat Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD (2008) Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 31:2131–2135PubMedCrossRef Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD (2008) Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 31:2131–2135PubMedCrossRef
8.
Zurück zum Zitat Gulliford MC, Dodhia H, Chamley M et al (2010) Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med 27:282–288PubMedCrossRef Gulliford MC, Dodhia H, Chamley M et al (2010) Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med 27:282–288PubMedCrossRef
9.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRef Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRef
10.
Zurück zum Zitat Kohner EM, Aldington SJ, Stratton IM et al (1998) United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116:297–303PubMedCrossRef Kohner EM, Aldington SJ, Stratton IM et al (1998) United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116:297–303PubMedCrossRef
11.
Zurück zum Zitat Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:2335–2342PubMedCrossRef Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:2335–2342PubMedCrossRef
12.
Zurück zum Zitat Misra A, Bachmann MO, Greenwood RH et al (2009) Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26:1040–1047PubMedCrossRef Misra A, Bachmann MO, Greenwood RH et al (2009) Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26:1040–1047PubMedCrossRef
13.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
14.
Zurück zum Zitat Thomas RL, Dunstan F, Luzio SD et al (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344:e874PubMedCrossRef Thomas RL, Dunstan F, Luzio SD et al (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344:e874PubMedCrossRef
15.
Zurück zum Zitat Younis N, Broadbent DM, Vora JP, Harding SP, The Liverpool Diabetic Eye Study Group (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361:195–200PubMedCrossRef Younis N, Broadbent DM, Vora JP, Harding SP, The Liverpool Diabetic Eye Study Group (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361:195–200PubMedCrossRef
16.
Zurück zum Zitat Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806 Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806
17.
Zurück zum Zitat NHS Diabetic Eye Screening Programme (2007) National screening programme for diabetic retinopathy workbook. NHS Diabetic Eye Screening Programme NHS Diabetic Eye Screening Programme (2007) National screening programme for diabetic retinopathy workbook. NHS Diabetic Eye Screening Programme
18.
Zurück zum Zitat Stata Corporation (2012) Stata statistical software. In. Stata Press, College Station, TX, USA Stata Corporation (2012) Stata statistical software. In. Stata Press, College Station, TX, USA
19.
Zurück zum Zitat Department of Health (2004) GP Bulletin, 31 Department of Health (2004) GP Bulletin, 31
20.
Zurück zum Zitat Ashworth M, Jenkins M, Burgess K et al (2005) Which general practices have higher list inflation? An exploratory study. Fam Pract 22:529–531PubMedCrossRef Ashworth M, Jenkins M, Burgess K et al (2005) Which general practices have higher list inflation? An exploratory study. Fam Pract 22:529–531PubMedCrossRef
21.
Zurück zum Zitat Zhang X, Norris SL, Saadine J et al (2007) Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med 33:318–335PubMedCrossRef Zhang X, Norris SL, Saadine J et al (2007) Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med 33:318–335PubMedCrossRef
22.
Zurück zum Zitat Olafsdottir E, Stefansson E (2007) Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91:1599–1601PubMedCrossRef Olafsdottir E, Stefansson E (2007) Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91:1599–1601PubMedCrossRef
23.
Zurück zum Zitat Jones CD, Greenwood RH, Misra A, Bachmann MO (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596PubMedCrossRef Jones CD, Greenwood RH, Misra A, Bachmann MO (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592–596PubMedCrossRef
24.
Zurück zum Zitat Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319PubMedCrossRef Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318–1319PubMedCrossRef
Metadaten
Titel
Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study
Publikationsdatum
01.10.2013
Erschienen in
Diabetologia / Ausgabe 10/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2975-0

Weitere Artikel der Ausgabe 10/2013

Diabetologia 10/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.